Arcadia Biosciences to Participate in Upcoming Investor Conferences

DAVIS, Calif. (August 31, 2022) – Arcadia Biosciences, Inc.^® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and Pam Haley, CFO, will be participating in two investor conferences during the month of September.

• H.C. Wainwright 24^th Annual Global Investment Conference. Arcadia will be featured as a presenting company at the conference, to be held September 12-14, 2022 at the Lotte Palace Hotel in New York City. Stan Jacot, Arcadia’s president and CEO will present a business overview at 5:00 p.m. ET on Tuesday, September 13 and will be available for in-person meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hcwevents.com/annualconference.
• Lake Street Capital Markets’ 6^th Annual Best Ideas Growth (BIG6) Conference. Arcadia will also be conducting one-on-one investor meetings at Lake Street’s BIG6 Conference on September 14, 2022 at the Yale Club in New York City.

Jacot’s H.C. Wainwright presentation will be webcast live here, and a replay will be available in the Investors section of the Arcadia’s website.

About Arcadia Biosciences
Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating crops to provide high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products that make every body feel good, inside and out. The company’s food, beverage and body care products include GoodWheat™, Zola^® coconut water, ProVault™ topical pain relief and SoulSpring™ bath and body care. For more information, visit www.arcadiabio.com.

Arcadia Biosciences Contact:
T.J. Schaefer
ir@arcadiabio.com